Welcome Back How to Address the Decline in HPV Vaccination and Cervical Screening Rates

Presented By:
David T. Pride, MD, PhD
William A. Calo, PhD, JD, MPH

Speaker Biography:
Dr. Pride is originally from Nashville, Tennessee. He received his undergraduate degree in biology from Wake Forest University, his Ph.D. in Microbiology and Immunology from Vanderbilt University, and his M.D. at New York University. He is board certified in Internal Medicine and received subspecialty training in Infectious Diseases at Stanford University. Dr. Pride serves as the Director of the Microbiology laboratory at UC San Diego Health. He has been instrumental in leading the response to COVID-19 testing at UC San Diego Health. Dr. Pride's major interests are in developing diagnostic tests for infectious diseases, understanding the role of microbial communities in human health and disease. His research laboratory specializes in human microbiome research with a focus on viruses that inhabit the human microbiome. The laboratory also has a focus on understanding how to use bacteriophages to promote human health (phage therapy).
Dr. William Calo is an assistant professor in the Department of Public Health Sciences at the Penn State College of Medicine (PSCOM). He is also affiliated with the Department of Family and Community Medicine and the Penn State Cancer Institute. Dr. Calo ' s research program examines how to adapt, implement, and evaluate best practices to improve vaccine uptake among underserved communities, especially rural and Hispanic populations. Dr. Calo is currently focused on the study of communication and policy interventions to address vaccine hesitancy and improve HPV, COVID-19, and flu vaccination. He is the Principal Investigator of a National Cancer Institute-funded (MERIT R37) randomized controlled trial using a novel hybrid effectiveness-implementation design and the ECHO model to deliver communication best practices to rural primary care providers to improve HPV vaccination in Pennsylvania. With supplemental funding from the CDC, Dr. Calo is evaluating the use of community members as trusted messengers to overcome COVID-19 vaccine misinformation and promote vaccination among racial/ethnic minorities in Central Pennsylvania. He has over 45 publications on vaccine­ related topics. He serves as the co-leader for the Pennsylvania HPV Vaccination Workgroup, part of the Pennsylvania Cancer Control Program. He has been speaker in many national scientific conferences, including the 2021 National HPV Vaccination Roundtable.

Welcome Back: How to Address the Decline in HPV Vaccination and Cervical Screening Rates

Webinar Abstract:
Human papillomavirus (HPV) is responsible for more than 99% of cervical cancers. Most HPV infections are transient and are resolved by our immune system, however, persistent infections can cause cervical cancer in individuals with a cervix. Infection is extremely common and most sexually-active individuals (4 in 5) will be exposed to HPV by the age of 50. Vaccination and routine screening can prevent most HPV infections and cervical cancer cases thereby eliminating HPV-caused cervical cancers in the United States.

LabRoots on Social:
Facebook: https://www.facebook.com/LabRootsInc
Twitter: https://twitter.com/LabRoots
LinkedIn: https://www.linkedin.com/company/labroots
Instagram: https://www.instagram.com/labrootsinc
Pinterest: https://www.pinterest.com/labroots/
SnapChat: labroots_inc
Web design
Be the first to comment